Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis.

Botha H, Mantyh WG, Murray ME, Knopman DS, Przybelski SA, Wiste HJ, Graff-Radford J, Josephs KA, Schwarz CG, Kremers WK, Boeve BF, Petersen RC, Machulda MM, Parisi JE, Dickson DW, Lowe V, Jack CR Jr, Jones DT.

Brain. 2018 Apr 1;141(4):1201-1217. doi: 10.1093/brain/awy049.

PMID:
29538658
2.

Longitudinal tau PET in ageing and Alzheimer's disease.

Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, Weigand SD, Therneau TM, Knopman DS, Gunter JL, Jones DT, Graff-Radford J, Kantarci K, Roberts RO, Mielke MM, Machulda MM, Petersen RC.

Brain. 2018 May 1;141(5):1517-1528. doi: 10.1093/brain/awy059.

3.

Tau-negative amnestic dementia masquerading as Alzheimer disease dementia.

Botha H, Mantyh WG, Graff-Radford J, Machulda MM, Przybelski SA, Wiste HJ, Senjem ML, Parisi JE, Petersen RC, Murray ME, Boeve BF, Lowe VJ, Knopman DS, Jack CR Jr, Jones DT.

Neurology. 2018 Mar 13;90(11):e940-e946. doi: 10.1212/WNL.0000000000005124. Epub 2018 Feb 7.

PMID:
29438037
4.

Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.

Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.

Brain. 2018 Jan 1;141(1):271-287. doi: 10.1093/brain/awx320.

5.

Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.

Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, Botha H, Kantarci K, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Cortex. 2017 Dec;97:143-159. doi: 10.1016/j.cortex.2017.09.018. Epub 2017 Oct 3.

6.

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.

Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Knopman DS, Lowe V, Vemuri P, Mielke MM, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC.

Lancet Neurol. 2017 Jun;16(6):435-444. doi: 10.1016/S1474-4422(17)30077-7. Epub 2017 Apr 26.

7.

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity.

Schwarz CG, Gunter JL, Wiste HJ, Przybelski SA, Weigand SD, Ward CP, Senjem ML, Vemuri P, Murray ME, Dickson DW, Parisi JE, Kantarci K, Weiner MW, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2016 May 30;11:802-812. doi: 10.1016/j.nicl.2016.05.017. eCollection 2016.

8.

Defining imaging biomarker cut points for brain aging and Alzheimer's disease.

Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Gunter JL, Senjem ML, Jones DT, Kantarci K, Machulda MM, Mielke MM, Roberts RO, Vemuri P, Reyes DA, Petersen RC.

Alzheimers Dement. 2017 Mar;13(3):205-216. doi: 10.1016/j.jalz.2016.08.005. Epub 2016 Sep 30.

9.

[Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status.

Machulda MM, Hagen CE, Wiste HJ, Mielke MM, Knopman DS, Roberts RO, Vemuri P, Lowe VJ, Jack CR Jr, Petersen RC.

Clin Neuropsychol. 2017 Jan;31(1):99-117. doi: 10.1080/13854046.2016.1241303. Epub 2016 Oct 11.

10.

Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC.

Neurology. 2016 Aug 16;87(7):691-8. doi: 10.1212/WNL.0000000000002979. Epub 2016 Jul 15.

11.

Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study.

Jack CR Jr, Therneau TM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Mielke MM, Vemuri P, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC.

Lancet Neurol. 2016 Jan;15(1):56-64. doi: 10.1016/S1474-4422(15)00323-3. Epub 2015 Nov 18.

12.

Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community.

Petersen RC, Wiste HJ, Weigand SD, Rocca WA, Roberts RO, Mielke MM, Lowe VJ, Knopman DS, Pankratz VS, Machulda MM, Geda YE, Jack CR Jr.

JAMA Neurol. 2016 Jan;73(1):85-92. doi: 10.1001/jamaneurol.2015.3098. Erratum in: JAMA Neurol. 2016 Apr;73(4):481.

13.

Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.

Knopman DS, Jack CR Jr, Lundt ES, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC.

JAMA Neurol. 2015 Dec;72(12):1475-83. doi: 10.1001/jamaneurol.2015.2323.

14.

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings.

Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Mielke MM, Vemuri P, Lowe V, Senjem ML, Gunter JL, Reyes D, Machulda MM, Roberts R, Petersen RC.

Brain. 2015 Dec;138(Pt 12):3747-59. doi: 10.1093/brain/awv283. Epub 2015 Sep 30.

15.

Left ventricular hypertrophy after hypertensive pregnancy disorders.

Scantlebury DC, Kane GC, Wiste HJ, Bailey KR, Turner ST, Arnett DK, Devereux RB, Mosley TH Jr, Hunt SC, Weder AB, Rodriguez B, Boerwinkle E, Weissgerber TL, Garovic VD.

Heart. 2015 Oct;101(19):1584-90. doi: 10.1136/heartjnl-2015-308098. Epub 2015 Aug 4.

16.

Clinical Outcomes of Cardiac Resynchronization with Epicardial Left Ventricular Lead.

Chen L, Fu H, Pretorius VG, Yang D, Wiste HJ, Yuan H, Feld GK, Cha YM, Birgersdotter-Green UM.

Pacing Clin Electrophysiol. 2015 Oct;38(10):1201-9. doi: 10.1111/pace.12687. Epub 2015 Aug 13.

PMID:
26172535
17.

Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial.

Choi JO, Daly RC, Lin G, Lahr BD, Wiste HJ, Beaver TM, Iacovoni A, Malinowski M, Friedrich I, Rouleau JL, Favaloro RR, Sopko G, Lang IM, White HD, Milano CA, Jones RH, Lee KL, Velazquez EJ, Oh JK.

Eur J Heart Fail. 2015 Apr;17(4):453-63. doi: 10.1002/ejhf.256. Epub 2015 Mar 16.

18.

Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.

Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Vemuri P, Mielke MM, Lowe V, Senjem ML, Gunter JL, Machulda MM, Gregg BE, Pankratz VS, Rocca WA, Petersen RC.

JAMA Neurol. 2015 May;72(5):511-9. doi: 10.1001/jamaneurol.2014.4821.

19.

Sleep disordered breathing and acute mountain sickness in workers rapidly transported to the South Pole (2835 m).

Anderson PJ, Wiste HJ, Ostby SA, Miller AD, Ceridon ML, Johnson BD.

Respir Physiol Neurobiol. 2015 May;210:38-43. doi: 10.1016/j.resp.2015.01.012. Epub 2015 Feb 3.

PMID:
25655218
20.

Effects of tricuspid valve regurgitation on outcome in patients with cardiac resynchronization therapy.

Grupper A, Killu AM, Friedman PA, Abu Sham'a R, Buber J, Kuperstein R, Rozen G, Asirvatham SJ, Espinosa RE, Luria D, Webster TL, Brooke KL, Hodge DO, Wiste HJ, Cha YM, Glikson M.

Am J Cardiol. 2015 Mar 15;115(6):783-9. doi: 10.1016/j.amjcard.2014.12.046. Epub 2015 Jan 6.

PMID:
25638518
21.

Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.

Mielke MM, Weigand SD, Wiste HJ, Vemuri P, Machulda MM, Knopman DS, Lowe V, Roberts RO, Kantarci K, Rocca WA, Jack CR Jr, Petersen RC.

Alzheimers Dement. 2014 Nov;10(6):779-89. doi: 10.1016/j.jalz.2014.09.001. Epub 2014 Nov 15.

22.

Spontaneous amyloid-related imaging abnormalities in a cognitively normal adult.

Raman MR, Wiste HJ, Senjem ML, Ward CP, Jack CR Jr, Kantarci K.

Neurology. 2014 Nov 4;83(19):1771-2. doi: 10.1212/WNL.0000000000000957. No abstract available.

23.

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.

Jack CR Jr, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Preboske GM, Pankratz VS, Vemuri P, Petersen RC.

Lancet Neurol. 2014 Oct;13(10):997-1005. doi: 10.1016/S1474-4422(14)70194-2. Epub 2014 Sep 4.

24.

Effects of atrioventricular conduction delay on the outcome of cardiac resynchronization therapy.

Lee YH, Wu JH, Asirvatham SJ, Del Carpio Munoz F, Webster T, Brooke KL, Hodge DO, Wiste HJ, Friedman PA, Cha YM.

J Electrocardiol. 2014 Nov-Dec;47(6):930-5. doi: 10.1016/j.jelectrocard.2014.07.024. Epub 2014 Aug 2.

PMID:
25169796
25.

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration.

Jack CR Jr, Wiste HJ, Knopman DS, Vemuri P, Mielke MM, Weigand SD, Senjem ML, Gunter JL, Lowe V, Gregg BE, Pankratz VS, Petersen RC.

Neurology. 2014 May 6;82(18):1605-12. doi: 10.1212/WNL.0000000000000386. Epub 2014 Apr 4.

26.

18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.

Knopman DS, Jack CR Jr, Wiste HJ, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

Neurobiol Aging. 2014 Sep;35(9):2096-106. doi: 10.1016/j.neurobiolaging.2014.03.006. Epub 2014 Mar 11.

27.

Echocardiographic diagnosis of constrictive pericarditis: Mayo Clinic criteria.

Welch TD, Ling LH, Espinosa RE, Anavekar NS, Wiste HJ, Lahr BD, Schaff HV, Oh JK.

Circ Cardiovasc Imaging. 2014 May;7(3):526-34. doi: 10.1161/CIRCIMAGING.113.001613. Epub 2014 Mar 14.

PMID:
24633783
28.

Predictors and outcomes of "super-response" to cardiac resynchronization therapy.

Killu AM, Grupper A, Friedman PA, Powell BD, Asirvatham SJ, Espinosa RE, Luria D, Rozen G, Buber J, Lee YH, Webster T, Brooke KL, Hodge DO, Wiste HJ, Glikson M, Cha YM.

J Card Fail. 2014 Jun;20(6):379-86. doi: 10.1016/j.cardfail.2014.03.001. Epub 2014 Mar 12.

PMID:
24632340
29.

Head trauma and in vivo measures of amyloid and neurodegeneration in a population-based study.

Mielke MM, Savica R, Wiste HJ, Weigand SD, Vemuri P, Knopman DS, Lowe VJ, Roberts RO, Machulda MM, Geda YE, Petersen RC, Jack CR Jr.

Neurology. 2014 Jan 7;82(1):70-6. doi: 10.1212/01.wnl.0000438229.56094.54. Epub 2013 Dec 26.

30.

Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity.

Jack CR Jr, Wiste HJ, Weigand SD, Knopman DS, Lowe V, Vemuri P, Mielke MM, Jones DT, Senjem ML, Gunter JL, Gregg BE, Pankratz VS, Petersen RC.

Neurology. 2013 Nov 12;81(20):1732-40. doi: 10.1212/01.wnl.0000435556.21319.e4. Epub 2013 Oct 16.

31.

Hypertension in pregnancy is a risk factor for microalbuminuria later in life.

Kattah AG, Asad R, Scantlebury DC, Bailey KR, Wiste HJ, Hunt SC, Mosley TH, Kardia SL, Turner ST, Garovic VD.

J Clin Hypertens (Greenwich). 2013 Sep;15(9):617-23. doi: 10.1111/jch.12116. Epub 2013 Apr 29.

32.

Hypertension in pregnancy is associated with elevated C-reactive protein levels later in life.

Brown CM, Turner ST, Bailey KR, Mosley TH Jr, Kardia SL, Wiste HJ, Kullo IJ, Garovic VD.

J Hypertens. 2013 Nov;31(11):2213-9; discussion 2219. doi: 10.1097/HJH.0b013e3283642f6c.

33.

Selective worsening of brain injury biomarker abnormalities in cognitively normal elderly persons with β-amyloidosis.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

JAMA Neurol. 2013 Aug;70(8):1030-8. doi: 10.1001/jamaneurol.2013.182.

34.

Hypertension in pregnancy is associated with elevated homocysteine levels later in life.

White WM, Turner ST, Bailey KR, Mosley TH Jr, Kardia SL, Wiste HJ, Kullo IJ, Garovic VD.

Am J Obstet Gynecol. 2013 Nov;209(5):454.e1-7. doi: 10.1016/j.ajog.2013.06.030. Epub 2013 Jun 19.

35.

Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy.

Weissgerber TL, Turner ST, Bailey KR, Mosley TH Jr, Kardia SL, Wiste HJ, Miller VM, Kullo IJ, Garovic VD.

Atherosclerosis. 2013 Jul;229(1):212-6. doi: 10.1016/j.atherosclerosis.2013.04.012. Epub 2013 Apr 18.

36.

Delayed intrinsicoid deflection onset in surface ECG lateral leads predicts left ventricular reverse remodeling after cardiac resynchronization therapy.

Del-Carpio Munoz F, Powell BD, Cha YM, Wiste HJ, Redfield MM, Friedman PA, Asirvatham SJ.

Heart Rhythm. 2013 Jul;10(7):979-87. doi: 10.1016/j.hrthm.2013.03.045. Epub 2013 Mar 28.

PMID:
23542361
37.

Brain β-amyloid load approaches a plateau.

Jack CR Jr, Wiste HJ, Lesnick TG, Weigand SD, Knopman DS, Vemuri P, Pankratz VS, Senjem ML, Gunter JL, Mielke MM, Lowe VJ, Boeve BF, Petersen RC.

Neurology. 2013 Mar 5;80(10):890-6. doi: 10.1212/WNL.0b013e3182840bbe. Epub 2013 Feb 27.

38.

Brain injury biomarkers are not dependent on β-amyloid in normal elderly.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC.

Ann Neurol. 2013 Apr;73(4):472-80. doi: 10.1002/ana.23816. Epub 2013 Feb 19.

39.

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ.

Lancet Neurol. 2013 Feb;12(2):207-16. doi: 10.1016/S1474-4422(12)70291-0.

40.

Outcomes of cardiac resynchronization therapy in the elderly.

Killu AM, Wu JH, Friedman PA, Shen WK, Webster TL, Brooke KL, Hodge DO, Wiste HJ, Cha YM.

Pacing Clin Electrophysiol. 2013 Jun;36(6):664-72. doi: 10.1111/pace.12048. Epub 2012 Dec 18.

PMID:
23252710
41.

Indicators of amyloid burden in a population-based study of cognitively normal elderly.

Mielke MM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Roberts RO, Geda YE, Swenson-Dravis DM, Boeve BF, Senjem ML, Vemuri P, Petersen RC, Jack CR Jr.

Neurology. 2012 Oct 9;79(15):1570-7. doi: 10.1212/WNL.0b013e31826e2696. Epub 2012 Sep 12.

42.

Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging.

Whitwell JL, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Roberts RO, Boeve BF, Petersen RC, Jack CR Jr; Alzheimer Disease Neuroimaging Initiative.

Arch Neurol. 2012 May;69(5):614-22. doi: 10.1001/archneurol.2011.3029.

43.

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Boeve BF, Petersen RC.

Neurology. 2012 May 15;78(20):1576-82. doi: 10.1212/WNL.0b013e3182563bbe. Epub 2012 May 2. Erratum in: Neurology. 2017 Aug 29;89(9):980.

44.

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.

Jack CR Jr, Knopman DS, Weigand SD, Wiste HJ, Vemuri P, Lowe V, Kantarci K, Gunter JL, Senjem ML, Ivnik RJ, Roberts RO, Rocca WA, Boeve BF, Petersen RC.

Ann Neurol. 2012 Jun;71(6):765-75. doi: 10.1002/ana.22628. Epub 2012 Apr 9.

45.

Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis.

Dong YX, Powell BD, Asirvatham SJ, Friedman PA, Rea RF, Webster TL, Brooke KL, Hodge DO, Wiste HJ, Yang YZ, Hayes DL, Cha YM.

Europace. 2012 Aug;14(8):1139-47. doi: 10.1093/europace/eus045. Epub 2012 Mar 30.

PMID:
22467754
46.

Shapes of the trajectories of 5 major biomarkers of Alzheimer disease.

Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Lowe V, Kantarci K, Bernstein MA, Senjem ML, Gunter JL, Boeve BF, Trojanowski JQ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Knopman DS; Alzheimer’s Disease Neuroimaging Initiative.

Arch Neurol. 2012 Jul;69(7):856-67.

47.

Core lab analysis of baseline echocardiographic studies in the STICH trial and recommendation for use of echocardiography in future clinical trials.

Oh JK, Pellikka PA, Panza JA, Biernat J, Attisano T, Manahan BG, Wiste HJ, Lin G, Lee K, Miller FA Jr, Stevens S, Sopko G, She L, Velazquez EJ; STICH Trial Investigators.

J Am Soc Echocardiogr. 2012 Mar;25(3):327-36. doi: 10.1016/j.echo.2011.12.002. Epub 2012 Jan 9.

48.

Impact of myocardial scarring on outcomes of cardiac resynchronization therapy: extent or location?

Xu YZ, Cha YM, Feng D, Powell BD, Wiste HJ, Hua W, Chareonthaitawee P.

J Nucl Med. 2012 Jan;53(1):47-54. doi: 10.2967/jnumed.111.095448. Epub 2011 Dec 12.

49.

Cardiac resynchronization therapy: do women benefit more than men?

Xu YZ, Friedman PA, Webster T, Brooke K, Hodge DO, Wiste HJ, Hua W, Zhang S, Hayes DL, Cha YM.

J Cardiovasc Electrophysiol. 2012 Feb;23(2):172-8. doi: 10.1111/j.1540-8167.2011.02168.x. Epub 2011 Sep 13.

PMID:
21914024
50.

Evidence for ordering of Alzheimer disease biomarkers.

Jack CR Jr, Vemuri P, Wiste HJ, Weigand SD, Aisen PS, Trojanowski JQ, Shaw LM, Bernstein MA, Petersen RC, Weiner MW, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Dec;68(12):1526-35. doi: 10.1001/archneurol.2011.183. Epub 2011 Aug 8.

Supplemental Content

Loading ...
Support Center